Diabetes

Technophobia may keep seniors from using apps to manage diabetes

Despite showing interest in web or mobile apps to help manage their Type 2 diabetes, only a small number of older adults actually use them, says a new study from the University of Waterloo. Approximately 2.2 million Canadians ...

Cardiology

Diabetes drug shown not to increase heart failure risk

People with the most common form of diabetes can take the new drug Alogliptin without concern for an increased risk of heart failure or cardiovascular disease, according to research by a UConn cardiologist just published ...

Diabetes

Pre-diabetes label 'unhelpful and unnecessary'

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.

Diabetes

Metformin may increase risk of cognitive impairment

(HealthDay)—Metformin may increase the risk of cognitive impairment in patients with diabetes; however, calcium supplementation may attenuate this risk, according to research published online Sept. 5 in Diabetes Care.

Overweight & Obesity

Type 2 diabetes tablet promotes weight loss

(Medical Xpress)—A new drug for type 2 diabetes, involving research at Aston University is being launched as a once-daily tablet for adults with the condition.

Diabetes

Low serum 25(OH)D3 in patients newly diagnosed with T2DM

(HealthDay)—Serum 25-hydroxyvitamin D3 (25[OH]D3) is associated with glucose-stimulated insulin secretion and β-cell function in individuals with newly diagnosed type 2 diabetes, according to a study published online June ...

page 11 from 40